|
|
||||||||
Ann Thorac Surg 2000;70:327-334
© 2000 The Society of Thoracic Surgeons
a Department of Surgery, Columbia Presbyterian Medical Center, New York, New York, USA
b Department of Neurology, University of Texas Southwestern Medical Center, Dallas, Texas, USA
c Neurology Service, William Beaumont Hospital, Royal Oak, Michigan, USA
d Departments of Neurology and Neurosciences, Case Western Reserve University, Department of Veterans Affairs Medical Center, University Hospitals of Cleveland, Cleveland, Ohio, USA
e Department of Neurology, University of California at Los Angeles, Los Angeles, California, USA
f National Institute for Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA
g Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA
Address reprint requests to The Myasthenia Gravis Foundation of America, Inc, 123 West Madison, Suite 800, Chicago, IL 60602
e-mail: myastheniagravis@msn.com
The need for universally accepted classifications, grading systems, and methods of analysis for patients undergoing therapy for MG is widely recognized and is particularly needed for therapeutic research trials. The Medical Scientific Advisory Board (MSAB) of the Myasthenia Gravis Foundation of America (MGFA) formed a Task Force in May 1997 to address these issues. Initially, the Task Force planned to develop classifications and outcome measures pertaining only to standardizing thymectomy trials. However, it quickly became apparent that their efforts should apply to all therapeutic trials for MG, and thus the scope of the mission was expanded.
During the development of these recommendations, the Task Force faced numerous dilemmas for which no universally satisfactory solution was available. Dilemmas were defined as "situations that require one to choose between two equally balanced alternatives or predicaments that seemingly defy satisfactory solutions." The Task Force members agreed at the outset, however, that their primary goal was to develop a uniform set of classifications to be used in the comparative analysis of the various therapeutic interventions for MG. With this as the primary goal, a consensus was gradually developed. In developing a consensus, at least two meetings were held each year during a 3-year period. Between meetings there was exchange of all proposals by electronic and surface mail, consultation with national and international experts in the field, critical analysis of all proposals, and many revisions. All conflicts (both minor and major) were resolved by vote. Virtually all issues were eventually approved unanimously; a few received a plurality of six.
This report presents the work of the Task Force and proposes classification systems and definitions of response to therapy designed to achieve more uniformity in recording and reporting clinical trials and outcomes research. Although designed primarily for research purposes, we think physicians may find some of
Related Article
Ann. Thorac. Surg. 2000 70: 334.
This article has been cited by other articles:
![]() |
C. Prokakis, E. Koletsis, S. Salakou, E. Apostolakis, N. Baltayiannis, A. Chatzimichalis, T. Papapetropoulos, and D. Dougenis Modified maximal thymectomy for myasthenia gravis: effect of maximal resection on late neurologic outcome and predictors of disease remission. Ann. Thorac. Surg., November 1, 2009; 88(5): 1638 - 1645. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Fleck, M. Fleck, M. Muller, H. Hager, W. Klepetko, E. Wolner, and W. Wisser Extended videoscopic robotic thymectomy with the da Vinci telemanipulator for the treatment of myasthenia gravis: the Vienna experience Interactive CardioVascular and Thoracic Surgery, November 1, 2009; 9(5): 784 - 787. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Pompeo, F. Tacconi, R. Massa, D. Mineo, S. Nahmias, and T. C. Mineo Long-term outcome of thoracoscopic extended thymectomy for nonthymomatous myasthenia gravis Eur. J. Cardiothorac. Surg., July 1, 2009; 36(1): 164 - 169. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Meacci, A. Cesario, S. Margaritora, V. Porziella, A. Tessitore, G. Cusumano, A. Evoli, and P. Granone Thymectomy in myasthenia gravis via original video-assisted infra-mammary cosmetic incision and median sternotomy: long-term results in 180 patients Eur. J. Cardiothorac. Surg., June 1, 2009; 35(6): 1063 - 1069. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lucchi, R. Ricciardi, F. Melfi, L. Duranti, F. Basolo, G. Palmiero, L. Murri, and A. Mussi Association of thymoma and myasthenia gravis: oncological and neurological results of the surgical treatment Eur. J. Cardiothorac. Surg., May 1, 2009; 35(5): 812 - 816. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Toba, K. Kondo, H. Takizawa, and A. Tangoku Recurrent thymoma with a pleural dissemination invading the intervertebral foramen Eur. J. Cardiothorac. Surg., May 1, 2009; 35(5): 917 - 919. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Meyer, M. A. Herbert, N. C. Sobhani, P. Tavakolian, A. Duncan, M. Bruns, K. Korngut, J. Williams, S. L. Prince, L. Huber, et al. Comparative clinical outcomes of thymectomy for myasthenia gravis performed by extended transsternal and minimally invasive approaches. Ann. Thorac. Surg., February 1, 2009; 87(2): 385 - 390. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Soon and T. Agasthian Harmonic Scalpel in Video-Assisted Thoracoscopic Thymic Resections Asian Cardiovasc Thorac Ann, October 1, 2008; 16(5): 366 - 369. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Aghajanzadeh, H. Khoshrang, A. Mohammadzadeh, S. A Roudbari, and A. R Ghayeghran Thymectomy for Myasthenia Gravis: Prognostic Factors in 70 Patients Asian Cardiovasc Thorac Ann, October 1, 2007; 15(5): 371 - 375. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jaretzki III and J. R. Sonett Evaluation of Results of Thymectomy for MG Requires Accepted Standards Ann. Thorac. Surg., July 1, 2007; 84(1): 360 - 361. [Full Text] [PDF] |
||||
![]() |
L. Zinman, E. Ng, and V. Bril IV immunoglobulin in patients with myasthenia gravis: A randomized controlled trial Neurology, March 13, 2007; 68(11): 837 - 841. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Deymeer, O. Gungor-Tuncer, V. Yilmaz, Y. Parman, P. Serdaroglu, C. Ozdemir, A. Vincent, and G. Saruhan-Direskeneli Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis Neurology, February 20, 2007; 68(8): 609 - 611. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. K. Park, S. S. Choi, J. G. Lee, D. J. Kim, and K. Y. Chung Complete stable remission after extended transsternal thymectomy in myasthenia gravis. Eur. J. Cardiothorac. Surg., September 1, 2006; 30(3): 525 - 528. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Tomulescu, V. Ion, A. Kosa, O. Sgarbura, and I. Popescu Thoracoscopic thymectomy mid-term results. Ann. Thorac. Surg., September 1, 2006; 82(3): 1003 - 1007. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sekine, N. Kawaguchi, C. Hamada, H. Sekiguchi, K. Yasufuku, A. Iyoda, K. Shibuya, and T. Fujisawa Does perioperative high-dose prednisolone have clinical benefits for generalized myasthenia gravis? Eur. J. Cardiothorac. Surg., June 1, 2006; 29(6): 908 - 913. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Farrugia, M. D. Robson, L. Clover, P. Anslow, J. Newsom-Davis, R. Kennett, D. Hilton-Jones, P. M. Matthews, and A. Vincent MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis Brain, June 1, 2006; 129(6): 1481 - 1492. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-S. Hsu, C.-S. Huang, B.-S. Huang, H.-C. Lee, K.-P. Kao, W.-H. Hsu, and M.-H. Huang Thymoma is associated with relapse of symptoms after transsternal thymectomy for myasthenia gravis Interactive CardioVascular and Thoracic Surgery, February 1, 2006; 5(1): 42 - 46. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kattach, K. Anastasiadis, J. Cleuziou, C. Buckley, B. Shine, R. Pillai, and C. Ratnatunga Transsternal Thymectomy for Myasthenia Gravis: Surgical Outcome Ann. Thorac. Surg., January 1, 2006; 81(1): 305 - 308. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Nancy and S. Berrih-Aknin Differential Estrogen Receptor Expression in Autoimmune Myasthenia Gravis Endocrinology, May 1, 2005; 146(5): 2345 - 2353. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Granetzny, A. Hatem, A. Shalaby, and A. Boseila Manubriotomy versus median sternotomy in thymectomy for myasthenia gravis. Evaluation of the pulmonary status Eur. J. Cardiothorac. Surg., March 1, 2005; 27(3): 361 - 366. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Endo, T. Yamaguchi, N. Saito, S. Otani, T. Hasegawa, Y. Sato, and Y. Sohara Experience with programmed steroid treatment with thymectomy in nonthymomatous myasthenia gravis Ann. Thorac. Surg., May 1, 2004; 77(5): 1745 - 1750. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jaretzki III, J. A. Aarli, H. J. Kaminski, L. H. Phillips II, and D. B. Sanders Preoperative preparation of patients with myasthenia gravis forestalls postoperative respiratory complications after thymectomy Ann. Thorac. Surg., March 1, 2003; 75(3): 1068 - 1068. [Full Text] [PDF] |
||||
![]() |
R. C. Ashton Jr, K. M. McGinnis, C. P. Connery, D. G. Swistel, D. R. Ewing, and J. J. DeRose Jr Totally endoscopic robotic thymectomy for myasthenia gravis Ann. Thorac. Surg., February 1, 2003; 75(2): 569 - 571. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Savcenko, G. K. Wendt, S. L. Prince, and M. J. Mack Video-assisted thymectomy for myasthenia gravis: an update of a single institution experience Eur. J. Cardiothorac. Surg., December 1, 2002; 22(6): 978 - 983. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Budde and J. I. Miller Jr Problems in the evaluation of thymectomy for myasthenia gravis: Reply Ann. Thorac. Surg., March 1, 2002; 73(3): 1028 - 1028. [Full Text] [PDF] |
||||
![]() |
J. Kas, D. Kiss, V. Simon, E. Svastics, L. Major, and A. Szobor Decade-long experience with surgical therapy of myasthenia gravis: early complications of 324 transsternal thymectomies Ann. Thorac. Surg., November 1, 2001; 72(5): 1691 - 1697. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Salakou, A.C. Tsamandas, D.S. Bonikos, T. Papapetropoulos, and D. Dougenis The potential role of bcl-2, bax, and Ki67 expression in thymus of patients with myasthenia gravis, and their correlation with clinicopathologic parameters Eur. J. Cardiothorac. Surg., October 1, 2001; 20(4): 712 - 721. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Granone, S. Margaritora, A. Cesario, and D. Galetta Focus on cosmesis in thymectomy for myasthenia gravis Ann. Thorac. Surg., October 1, 2001; 72(4): 1441 - 1442. [Full Text] [PDF] |
||||
![]() |
J. M. Budde, C. D. Morris, A. A. Gal, K. A. Mansour, and J. I. Miller Jr Predictors of outcome in thymectomy for myasthenia gravis Ann. Thorac. Surg., July 1, 2001; 72(1): 197 - 202. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mussi, M. Lucchi, L. Murri, R. Ricciardi, L. Luchini, and C. A. Angeletti Extended thymectomy in myasthenia gravis: a team-work of neurologist, thoracic surgeon and anaesthesist may improve the outcome Eur. J. Cardiothorac. Surg., May 1, 2001; 19(5): 570 - 575. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |